According to AstraZeneca's latest financial reports the company's current earnings (TTM) are $8.49 B. an increase over its 2022 earnings that were of $3.83 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $8.49 B | 121.8% |
2022 | $3.83 B | 278.83% |
2021 | $1.01 B | -80.51% |
2020 | $5.18 B | 75.86% |
2019 | $2.95 B | -12.18% |
2018 | $3.35 B | -6.54% |
2017 | $3.59 B | -26.94% |
2016 | $4.91 B | 19.74% |
2015 | $4.10 B | 86.05% |
2014 | $2.20 B | -41.35% |
2013 | $3.76 B | -54.57% |
2012 | $8.28 B | -37.9% |
2011 | $13.34 B | 11.18% |
2010 | $12.00 B | 0% |
2009 | $12.00 B | 31.29% |
2008 | $9.14 B | 12.97% |
2007 | $8.09 B | 0.97% |
2006 | $8.01 B | 23.29% |
2005 | $6.50 B | -2526.12% |
2004 | -$0.27 B | -106.52% |
2003 | $4.11 B | 3.54% |
2002 | $3.97 B | -33.34% |
2001 | $5.95 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | 99.79% | ๐บ๐ธ USA |
Novartis NVS | $9.43 B | 11.10% | ๐จ๐ญ Switzerland |
Pfizer PFE | $3.26 B | -61.54% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $6.66 B | -21.55% | ๐บ๐ธ USA |
Eli Lilly LLY | $6.55 B | -22.84% | ๐บ๐ธ USA |
Sanofi SNY | $8.39 B | -1.17% | ๐ซ๐ท France |
Biogen BIIB | $1.29 B | -84.73% | ๐บ๐ธ USA |
Merck MRK | $3.03 B | -64.27% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $8.44 B | -0.65% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $7.53 B | -11.30% | ๐ฌ๐ง UK |